EUVIMEDEUVIMED entdecken
Crossref

Advanced glycation end products inhibit proliferation and primary cilia formation of myoblasts through receptor for advanced glycation end products pathway

Shinichiro Suzuki, Tatsuya Hayashi, Tatsuro Egawa

Biochemical and Biophysical Research Communications · 2023

DOI: 10.1016/j.bbrc.2023.149141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2023. Verfasst von Shinichiro Suzuki und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Health and Exercise Sciences, Graduate School of Human and Environmental Studies, Kyoto University, Kyoto, Japan. Electronic address: s…. Hauptthemen laut MEDLINE: Glycation End Products, Advanced, Cilia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Uehara Memorial Foundation, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The loss of skeletal muscle mass leads to various adverse conditions and shortened lifespan. The inhibition of myoblast proliferation is one of the causes that trigger muscle atrophy. Advanced glycation end products (AGEs) contribute to muscle atrophy. Since primary cilia are crucial organelles for proliferation, AGEs may inhibit primary cilia formation of myoblasts, thereby leading to impaired proliferation. Therefore, we aimed to clarify whether AGEs impeded the proliferation and formation of primary cilia of C2C12 skeletal muscle cells. AGE treatment inhibited the proliferation and formation of primary cilia. However, the inhibitor of the receptor for advanced glycosylation end products (RAGEs) abolished the inhibition of the proliferation and the primary cilia formation of C2C12 cells by AGEs, suggesting that AGEs cause these inhibitions through the RAGE pathway. In summary, our findings suggested that AGEs suppress the proliferation and formation of primary cilia of myoblasts through the RAGE pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycation End Products, AdvancedCiliaHumansReceptor for Advanced Glycation End ProductsMyoblastsMuscular AtrophyCell Proliferation

Stichwörter der Autor:innen

AGEsMyoblastPrimary ciliaProliferation

Substanzen

Receptor for Advanced Glycation End ProductsGlycation End Products, Advanced

Autor:innen und Institutionen

  • Laboratory of Health and Exercise Sciences, Graduate School of Human and Environmental Studies, Kyoto University, Kyoto, Japan. Electronic address: sisuzuki27@gmail.com.
  • Laboratory of Sports and Exercise Medicine, Graduate School of Human and Environmental Studies, Kyoto University, Kyoto, Japan.
  • Laboratory of Health and Exercise Sciences, Graduate School of Human and Environmental Studies, Kyoto University, Kyoto, Japan.

Förderung

  • Uehara Memorial Foundation
  • Japan Society for the Promotion of Science

Zitieren

APA

Suzuki, S., Hayashi, T., & Egawa, T. (2023). Advanced glycation end products inhibit proliferation and primary cilia formation of myoblasts through receptor for advanced glycation end products pathway. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2023.149141

Vancouver

Suzuki S, Hayashi T, Egawa T. Advanced glycation end products inhibit proliferation and primary cilia formation of myoblasts through receptor for advanced glycation end products pathway. Biochemical and Biophysical Research Communications. 2023. doi:10.1016/j.bbrc.2023.149141

BibTeX
@article{Suzuki2023,
  author = {Suzuki, Shinichiro and Hayashi, Tatsuya and Egawa, Tatsuro},
  title = {Advanced glycation end products inhibit proliferation and primary cilia formation of myoblasts through receptor for advanced glycation end products pathway},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2023},
  doi = {10.1016/j.bbrc.2023.149141}
}
Kostenlos starten →